Spire Healthcare Group (LON:SPI) Trading Up 14.1% - Here's Why

Key Points

• Spire Healthcare Group saw its stock price increase by 14.1% on Friday, reaching a last trading price of GBX 247 ($3.33), with over 9.7 million shares changing hands.
• Analysts give Spire a consensus rating of "Buy" with a price target of GBX 294.33, although JPMorgan reduced their price objective slightly to GBX 303.
• The company reported earnings of GBX 4.10 per share in its latest quarterly results, with forecasts suggesting an expected EPS of approximately 15.66 for the year.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price was up 14.1% during trading on Friday . The company traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). Approximately 9,747,062 shares were traded during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on SPI shares. JPMorgan Chase & Co. reduced their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Berenberg Bank restated a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Spire Healthcare Group currently has a consensus rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The stock has a market cap of £993.86 million, a PE ratio of 5,369.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company's 50 day simple moving average is GBX 218.75 and its 200 day simple moving average is GBX 203.41.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.